Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Uterine sarcoma
Keywords/Phrases:  leiomyosarcoma
Results 1-5 of 5 for your search:
Start Over
Alisertib in Treating Patients with Advanced or Metastatic Sarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A091102, NCI-2012-01991, CALGB-A091102, CDR0000737403, NCT01653028
Nivolumab in Treating Patients with Advanced Uterine Leiomyosarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9672, NCI-2014-02403, NCT02428192
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients with High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GOG-0277, NCI-2012-00249, CDR0000724874, IRCI 001, NCT01533207
Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-03-096, NCI-2013-01364, 13-014, NCT01958580
Clinical Manifestations and Genetic Defects in Identifying Disease Causality in Samples From Patients with Heritable Urologic Malignant Disorders
Phase: No phase specified
Type: Genetics, Natural history/Epidemiology
Age: Not specified
Trial IDs: 89-C-0086, NCI-2013-02066, 890086, NCT00019617, NCT00001238
Start Over